Ortoma AB Series B
The answer first
Does Ortoma beat the market?
No, Ortoma has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 33% of Nordic stocks
- Quality53
- Value8
- Trend67
No. 97 of 195 in healthcare
Max for seven days
Follow Ortoma with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Ortoma
Your first answer is free, no account needed.
Do you own Ortoma, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Ortoma and a few more. Free, no card.
Super Stock+44.6%In short
- Ortoma has fallen 26.3% over the past year, including dividends.
- Overall, Ortoma ranks better than 33% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 84.6%. The price is 87.3% below its peak now.
What do analysts think of Ortoma?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 33% of Nordic stocks.
No. 97 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 123 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity–
- Asset turnoverSales divided by everything the company owns0.17
- Return on equityProfit divided by equity−37.9%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 146 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity2.6
- P/SPrice divided by sales13.5
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 57 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+29.5%
- 6 months+18.7%
- 9 months−22.0%
- 12 months−26.3%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Ortoma
One fund we follow owns Ortoma. The share is how much of the fund the stock makes up.
- Sweden1
From the funds' latest known holdings.
About Ortoma
Ortoma AB Series B is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 14 employees.
Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position. The company was founded in 2001 and is based in Gothenburg, Sweden.


See the full analysis of Ortoma.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card